Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition comprising interleukin-2 and thymidine kinase for the treatment of tumors

Composition comprising interleukin-2 and thymidine kinase for the treatment of tumors

US Patent 6090378 · Granted Jul 18, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low dose IL-2 for treating autoimmune-related or inflammatory disorders2025
Virus-like particles which can be used in the treatment of allergies2025
Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and the2025
Zika virus chimeric polyepitope comprising non-structural proteins and its use i2024
Genetically modified T lymphocytes2023
Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders2023
Use of interleukin 2 for treating Sjögren's syndrome2022
Zika virus chimeric polyepitope comprising non-structural proteins and its use i2022
Virus-like particles which can be used in the treatment of autoimmune diseases2022
Compositions and methods for treatment of cytomegalovirus2022
Dengue virus chimeric polyepitope composed of fragments of non-structural protei2021
Use of low dose IL-2 for treating autoimmune—related or inflammatory disorders2020